-
1.发明授权Negative active material, method of preparing the same, and rechargeable lithium battery including the same 有权负极活性物质，其制备方法以及包含该负极活性物质的可再充电锂电池公开(公告)号：US09391314B2
公开(公告)日：2016-07-12
申请号：US12324943
申请日：2008-11-28
Applicant: Sang-Min Lee , Sung-Soo Kim , Goo-Jin Jeong , Nam-Soon Choi , Yong-Mook Kang , Min-Seok Sung , Leif Christensen
Inventor： Sang-Min Lee , Sung-Soo Kim , Goo-Jin Jeong , Nam-Soon Choi , Yong-Mook Kang , Min-Seok Sung , Leif Christensen
IPC: H01M4/38 , H01M4/134 , H01M4/1395 , H01M10/0525
CPC classification number: H01M4/134 , H01M4/1395 , H01M4/38 , H01M4/386 , H01M4/387 , H01M10/0525 , Y02E60/122
Abstract: A negative active material for rechargeable lithium batteries and a method of manufacturing the negative active material are provided. The negative active material for rechargeable lithium batteries includes at least one generally spherical assembly having flake-shaped materials that are capable of doping and dedoping lithium, and are arranged in a generally spherical shape defining a central pore. The negative active material imparts improved cycle-life characteristics.
Abstract translation: 提供了用于可再充电锂电池的负极活性材料和制造负极活性材料的方法。 用于可再充电锂电池的负极活性材料包括至少一个具有片状材料的通常为球形的组件，其能够掺杂和去掺杂锂，并且被布置为限定中心孔的大致球形。 负极活性物质具有改善的循环寿命特性。
-
公开(公告)号：US20100249029A1
公开(公告)日：2010-09-30
申请号：US12667778
申请日：2008-03-07
Applicant: Jens Breinholt , Kent Bondensgaard , Leif Christensen , Leif Nørskov-Lauritzen , Wang Lingyun , Gong Wei , Liu Yun , Sean Hu , Quinhong Ma
Inventor： Jens Breinholt , Kent Bondensgaard , Leif Christensen , Leif Nørskov-Lauritzen , Wang Lingyun , Gong Wei , Liu Yun , Sean Hu , Quinhong Ma
CPC classification number: C07K14/57554 , A61K38/00
Abstract: The invention relates to variants of prolactin, which variants have high affinity for the prolactin receptor.
Abstract translation: 本发明涉及催乳素的变体，该变体对催乳素受体具有高亲和力。
-
公开(公告)号：US20100035814A1
公开(公告)日：2010-02-11
申请号：US12513578
申请日：2007-11-09
Applicant: Bernd Peschke , Leif Christensen , Egon Persson
Inventor： Bernd Peschke , Leif Christensen , Egon Persson
IPC: A61K38/22 , C07K14/575 , C07K1/107 , A61P35/00
CPC classification number: C07K14/57554 , A61K47/60
Abstract: The invention is concerned with N-terminally pegylated polypeptides capable of binding to the prolactin receptor. Such polypeptides may for instance be N-terminally pegylated antagonists of the prolactin receptor, such as for instance prolactin variants.
Abstract translation: 本发明涉及能够结合催乳素受体的N-末端聚乙二醇化多肽。 这样的多肽可以例如是催乳素受体的N-末端聚乙二醇化的拮抗剂，例如催乳素变体。
-
公开(公告)号：US20100022454A1
公开(公告)日：2010-01-28
申请号：US12443309
申请日：2007-10-03
Applicant: Leif Norskov-Lauritsen , Leif Christensen
Inventor： Leif Norskov-Lauritsen , Leif Christensen
CPC classification number: C07K14/57554
Abstract: The present invention is concerned with peptides binding to the prolactin receptor, wherein said peptides have an improved binding via binding site 1 (BS1) to the prolactin receptor. In one embodiment, said improved binding is achieved by mutation of positions 61, 71 and 73.
Abstract translation: 本发明涉及与催乳素受体结合的肽，其中所述肽具有通过结合位点1（BS1）与催乳素受体的改善的结合。 在一个实施方案中，所述改进的结合通过位置61,71和73的突变实现。
-
公开(公告)号：US20090318353A1
公开(公告)日：2009-12-24
申请号：US12438280
申请日：2007-08-24
Applicant: Jesper Lau , Thomas Kruse Hansen , Leif Christensen , Kjeld Madsen , Lauge Schäffer , Jane Spetzler
Inventor： Jesper Lau , Thomas Kruse Hansen , Leif Christensen , Kjeld Madsen , Lauge Schäffer , Jane Spetzler
CPC classification number: C07K14/57563 , A61K38/00 , A61K38/26 , A61K47/542 , A61K47/543 , A61K47/545 , A61K47/60 , C07K14/605
Abstract: This invention provides new therapeutic peptides, i.e. new protracted Exendin-4 compounds, pharmaceutical compositions and the use of such.
Abstract translation: 本发明提供新的治疗肽，即新的延长的毒蜥外泌肽-4化合物，药物组合物及其用途。
-
Patent Agency Ranking
公开(公告)号：US07541430B2
公开(公告)日：2009-06-02
申请号：US11268268
申请日：2005-11-07
Applicant: Ulrich Sensfuss , Kilian Waldemar Conde Frieboes , Leif Christensen , Ingrid Vivika Petterson , Thomas Kruse Hansen , Michael Ankersen , Kjeld Madsen
Inventor： Ulrich Sensfuss , Kilian Waldemar Conde Frieboes , Leif Christensen , Ingrid Vivika Petterson , Thomas Kruse Hansen , Michael Ankersen , Kjeld Madsen
IPC: A61K38/10
Abstract: Novel cyclic and linear peptides of the formula R1—X—X1—X2—X3—X4—X5—X6—X7—X8—X9—X10—X11—R2 are useful in the treatment of obesity are provided.
Abstract translation: 式R1-X-X1-X2-X3-X4-X5-X6-X7-X8-X9-X10-X11-R2的新型环状和线性肽可用于治疗肥胖症。
-
公开(公告)号：US20080280820A1
公开(公告)日：2008-11-13
申请号：US11666795
申请日：2005-11-04
Applicant: Ulrich Sensfuss , Leif Christensen
Inventor： Ulrich Sensfuss , Leif Christensen
Abstract: The present invention relates to novel peptide compounds which are effective in modulating one or more melanocortin receptor types, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are of particular interest in relation to the treatment of obesity as well as a variety of diseases or conditions associated with obesity.
-
公开(公告)号：US20080248386A1
公开(公告)日：2008-10-09
申请号：US11696979
申请日：2007-04-05
Applicant: Mark N. Obrovac , Leif Christensen , Douglas C. Magnuson
Inventor： Mark N. Obrovac , Leif Christensen , Douglas C. Magnuson
CPC classification number: H01M4/1395 , H01M4/0404 , H01M4/0435 , H01M4/134 , H01M4/70 , H01M10/052 , H01M10/0587
Abstract: Provided is an electrode for an electrochemical cell that includes a current collector, and an active material in electrical contact with the current collector, wherein the electrode has a raised pattern as well as a method of making and using the same and also for electrochemical cells incorporating the same.
Abstract translation: 提供了一种用于电化学电池的电极，其包括集电器和与集电器电接触的活性材料，其中电极具有凸起图案以及制造和使用该电极的方法，并且还包括结合 一样。
-
公开(公告)号：US20080207493A1
公开(公告)日：2008-08-28
申请号：US11908173
申请日：2006-03-17
Applicant: Ingrid Pettersson , Leif Christensen
Inventor： Ingrid Pettersson , Leif Christensen
CPC classification number: C07K14/5759 , A61K38/00 , A61K47/542 , A61K47/62
Abstract: The present invention relates to novel peptide compounds which are effective in modulating one or more melanocortin receptor types, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are of particular interest in relation to the treatment of obesity as well as a variety of diseases or conditions associated with obesity.
Abstract translation: 本发明涉及有效调节一种或多种黑皮质素受体类型的新型肽化合物，治疗中化合物的用途，包括向有需要的患者施用化合物的治疗方法，以及使用 药物制造中的化合物。 本发明的化合物在治疗肥胖以及与肥胖相关的各种疾病或病症方面特别有意义。
-
公开(公告)号：US20080206641A1
公开(公告)日：2008-08-28
申请号：US11679591
申请日：2007-02-27
Applicant: Leif Christensen , Mark N. Obrovac
Inventor： Leif Christensen , Mark N. Obrovac
IPC: H01M4/58
CPC classification number: H01M4/134 , H01M4/0435 , H01M4/1393 , H01M4/386 , H01M4/622 , H01M4/625 , H01M10/052 , Y10T29/49108 , Y10T428/24
Abstract: A composite includes an active material, graphite, and a binder. The amount of graphite in the composite is greater than about 20 volume percent of the total volume of the active material and graphite in the composite. The porosity of the composite is less than about 20%.
Abstract translation: 复合材料包括活性材料，石墨和粘合剂。 复合材料中的石墨的量大于复合材料中活性材料和石墨的总体积的约20体积％。 复合材料的孔隙率小于约20％。
-
-
-
-
-
-
-
-
-
Search Results
59
records
(took 0.032 seconds)
